Pathophysiology of heart failure and frailty: a common inflammatory origin?

Abstract

SummaryFrailty, a clinical syndrome that typically occurs in older adults, implies a reduced ability to tolerate biological stressors. Frailty accompanies many age‐related diseases but can also occur without overt evidence of end‐organ disease. The condition is associated with circulating inflammatory cytokines and sarcopenia, features that are shared with heart failure (HF). However, the biological underpinnings of frailty remain unclear and the interaction with HF is complex. Here, we describe the inflammatory pathophysiology that is associated with frailty and speculate that the inflammation that occurs with frailty shares common origins with HF. We discuss the limitations in investigating the pathophysiology of frailty due to few relevant experimental models. Leveraging current therapies for advanced HF and current known therapies to address frailty in humans may enable translational studies to better understand the inflammatory interactions between frailty and HF.

How does cytomegalovirus factor into diseases of aging and vaccine responses, and by what mechanisms?

“…Frailty, which is characterized by a state of decreased physical activity and poor endurance, has been associated with clinical CVD (Bellumkonda et al 2017). As a result, it is possible that CMV infection also results in frailty via chronic inflammation and/or CVD.…”

Impact of delirium on postoperative frailty and long term cardiovascular events after cardiac surgery

“…The exact cause of why frailty is related to adverse outcomes remains unknown. However, it may be attributable to the systemic effects of cardiovascular disease, such as activation of inflammatory and neurohumoral processes and limitation of physical activity[ 11 ]. Such mechanisms may lead to worse clinical outcomes.…”

Investigation of the relationship between bladder function and sarcopenia using pressure flow studies in elderly male patients

“…Malnutrition, chronic inflammation, mitochondrial dysfunction, hormonal changes, and declines in neural function have been observed to play roles in the decrease of skeletal muscle mass and strength, leading to the development of sarcopenia . Recently, it has been reported that similar pathophysiological mechanisms contribute to cardiac dysfunction, including mitochondrial dysfunction, inflammation, and malnutrition, which implies that these factors could influence smooth muscle function as well as skeletal muscle function. Moreover, it was demonstrated that sarcopenia could worsen the functioning of the autonomic nervous system .…”